Topics

Gliomas | Prognosis | TERT promoter

Home > Publications > Topics > Gliomas > Prognosis > TERT promoter

*Cao W, Lan J, Hu C, Kong J, Xiang L, Zhang Z, Sun Y, Zeng Z, Lei S.
Predicting the prognosis of glioma patients with TERT promoter mutations and guiding the specific immune profile of immune checkpoint blockade therapy.
Aging (Albany NY). 2024 Mar 18;16. doi: 10.18632/aging.205668. PMID: 38499392. Observational study. ˍ

Xing H, Liu D, Li J, Ge Y, Guo X, Chen W, Zhao D, Shi Y, Li Y, Wang Y, Wang Y, Xia Y, Wu J, Liang T, Wang H, Liu Q, Jin S, Qu T, Guo S, Li H, Yang T, Zhang K, Wang Y, Ma W.
TERTp Mutation and its Prognostic Value in Glioma Patients Under the 2021 WHO Classification: A Real-World Study.
Cancer Med. 2025 Jan 13;14(2):e70533. doi: 10.1002/cam4.70533. PMID: 39804195. Observational study. ˍ